BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34355652)

  • 21. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells.
    Lee KH; Chang MY; Ahn JI; Yu DH; Jung SS; Choi JH; Noh YH; Lee YS; Ahn MJ
    Biochem Biophys Res Commun; 2002 Sep; 296(5):1125-33. PubMed ID: 12207890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML.
    Kahl M; Brioli A; Bens M; Perner F; Kresinsky A; Schnetzke U; Hinze A; Sbirkov Y; Stengel S; Simonetti G; Martinelli G; Petrie K; Zelent A; Böhmer FD; Groth M; Ernst T; Heidel FH; Scholl S; Hochhaus A; Schenk T
    Leukemia; 2019 Nov; 33(11):2628-2639. PubMed ID: 31576004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA HOTAIR regulates myeloid differentiation through the upregulation of p21 via miR-17-5p in acute myeloid leukaemia.
    Hu L; Liu J; Meng Y; Zheng H; Ding C; Wang H; Charwudzi A; Li M; Li J; Zhai Z; Xiong S
    RNA Biol; 2021 Oct; 18(10):1434-1444. PubMed ID: 33241756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia.
    Boutzen H; Saland E; Larrue C; de Toni F; Gales L; Castelli FA; Cathebas M; Zaghdoudi S; Stuani L; Kaoma T; Riscal R; Yang G; Hirsch P; David M; De Mas-Mansat V; Delabesse E; Vallar L; Delhommeau F; Jouanin I; Ouerfelli O; Le Cam L; Linares LK; Junot C; Portais JC; Vergez F; Récher C; Sarry JE
    J Exp Med; 2016 Apr; 213(4):483-97. PubMed ID: 26951332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-382-5p modulates the ATRA-induced differentiation of acute promyelocytic leukemia by targeting tumor suppressor PTEN.
    Liu D; Zhong L; Yuan Z; Yao J; Zhong P; Liu J; Yao S; Zhao Y; Liu L; Chen M; Li L; Liu B
    Cell Signal; 2019 Feb; 54():1-9. PubMed ID: 30453015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharicin B stabilizes retinoic acid receptor-α and presents synergistic differentiation induction with ATRA in myeloid leukemic cells.
    Gu ZM; Wu YL; Zhou MY; Liu CX; Xu HZ; Yan H; Zhao Y; Huang Y; Sun HD; Chen GQ
    Blood; 2010 Dec; 116(24):5289-97. PubMed ID: 20739655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. All-Trans Retinoic Acid Activity in Acute Myeloid Leukemia: Role of Cytochrome P450 Enzyme Expression by the Microenvironment.
    Su M; Alonso S; Jones JW; Yu J; Kane MA; Jones RJ; Ghiaur G
    PLoS One; 2015; 10(6):e0127790. PubMed ID: 26047326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fucosylation inhibitor 6-alkynylfucose enhances the ATRA-induced differentiation effect on acute promyelocytic leukemia cells.
    Suzuki S; Liu J; Sato Y; Miyake R; Suzuki S; Okitsu Y; Fukuda T; Isaji T; Gu J; Takahashi S
    Biochem Biophys Res Commun; 2024 May; 710():149541. PubMed ID: 38608490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emodin enhances ATRA-induced differentiation and induces apoptosis in acute myeloid leukemia cells.
    Chen Y; Li J; Hu J; Zheng J; Zheng Z; Liu T; Lin Z; Lin M
    Int J Oncol; 2014 Nov; 45(5):2076-84. PubMed ID: 25174432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells: candidate drugs for chemo-differentiation therapy against acute promyelocytic leukemia.
    Niitsu N; Higashihara M; Honma Y
    Exp Hematol; 2002 Nov; 30(11):1273-82. PubMed ID: 12423680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systems Biology for Drug Target Discovery in Acute Myeloid Leukemia.
    Novikova S; Tolstova T; Kurbatov L; Farafonova T; Tikhonova O; Soloveva N; Rusanov A; Zgoda V
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Bromodomain Inhibitor JQ1 Enhances the Responses to All-
    Kang C; Kim CY; Kim HS; Park SP; Chung HM
    Int J Stem Cells; 2018 May; 11(1):131-140. PubMed ID: 29699387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDK2 suppression synergizes with all-trans-retinoic acid to overcome the myeloid differentiation blockade of AML cells.
    Shao X; Xiang S; Fu H; Chen Y; Xu A; Liu Y; Qi X; Cao J; Zhu H; Yang B; He Q; Ying M
    Pharmacol Res; 2020 Jan; 151():104545. PubMed ID: 31740384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic priming of AML blasts for all-trans retinoic acid-induced differentiation by the HDAC class-I selective inhibitor entinostat.
    Blagitko-Dorfs N; Jiang Y; Duque-Afonso J; Hiller J; Yalcin A; Greve G; Abdelkarim M; Hackanson B; Lübbert M
    PLoS One; 2013; 8(10):e75258. PubMed ID: 24116031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of MYC by PI3K/AKT/mTOR pathway inhibition in combination with all-trans retinoic acid treatment for therapeutic gain in acute myeloid leukaemia.
    Stengel S; Petrie KR; Sbirkov Y; Stanko C; Ghazvini Zadegan F; Gil V; Skopek R; Kamiński P; Szymański Ł; Brioli A; Zelent A; Schenk T
    Br J Haematol; 2022 Jul; 198(2):338-348. PubMed ID: 35468223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia.
    Schenk T; Chen WC; Göllner S; Howell L; Jin L; Hebestreit K; Klein HU; Popescu AC; Burnett A; Mills K; Casero RA; Marton L; Woster P; Minden MD; Dugas M; Wang JC; Dick JE; Müller-Tidow C; Petrie K; Zelent A
    Nat Med; 2012 Mar; 18(4):605-11. PubMed ID: 22406747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wnt signaling is involved in 6-benzylthioinosine-induced AML cell differentiation.
    Zang S; Liu N; Wang H; Wald DN; Shao N; Zhang J; Ma D; Ji C; Tse W
    BMC Cancer; 2014 Nov; 14():886. PubMed ID: 25428027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells.
    Nishioka C; Ikezoe T; Yang J; Gery S; Koeffler HP; Yokoyama A
    Int J Cancer; 2009 Oct; 125(7):1710-20. PubMed ID: 19507250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.
    Shiohara M; Dawson MI; Hobbs PD; Sawai N; Higuchi T; Koike K; Komiyama A; Koeffler HP
    Blood; 1999 Mar; 93(6):2057-66. PubMed ID: 10068679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opposite regulation of vitamin D receptor by ATRA in AML cells susceptible and resistant to vitamin D-induced differentiation.
    Gocek E; Marchwicka A; Baurska H; Chrobak A; Marcinkowska E
    J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):220-6. PubMed ID: 22789609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.